+1-786-628-7980
Sign Up/Sign In 
Scleral Lenses Market Research Report: Information By Type (Corneo-Scleral Lenses and Semi-Scleral Lenses, Mini-Scleral Lenses, and Full Scleral Lenses), By Application (Irregular Cornea, Ocular Surface Disease, Refractive Error, and Other Applications), By End User (Hospitals, Eye Clinics, and Other End Users), And By Region (North America, Europe, Asia-Pacific, And Rest of The World) –Market Forecast Till 2032.
The Scleral Lenses Market industry is projected to grow from USD 0.30 Billion in 2023 to USD 0.50 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.80% during the forecast period (2023 – 2032).
The scleral lenses market is experiencing robust growth driven by rising cases of ocular conditions like keratoconus, dry eye syndrome, and corneal irregularities. These lenses offer improved comfort and vision correction for patients unsuitable for traditional contacts. Advancements in lens materials and manufacturing technologies enhance oxygen permeability and durability, boosting adoption rates. Additionally, increasing awareness among patients and eye care professionals about the benefits of scleral lenses fuels market expansion. Geographically, North America dominates the market due to high healthcare expenditure and technological advancements. However, Asia-Pacific shows significant potential for growth with expanding healthcare infrastructure and increasing disposable income.
Get Free Sample PDF Brochure @
https://www.marketresearchfuture.com/sample_request/19204
Segment Analysis
The global Scleral Lenses Market has been segmented based on the Type, Application, and End-User.
Based on the Type, the market is segmented into Corneo-Scleral Lenses and Semi-Scleral Lenses, Mini-Scleral Lenses, and Full Scleral Lenses. The Corneo-Scleral Lenses and Semi-Scleral Lenses segment was attributed to holding the largest market share in 2022. The corneoscleral lens addresses the limitations of both soft and rigid contact lenses. Offering a level of comfort comparable to soft lenses and enhanced acuity similar to rigid lenses, corneoscleral and semi-scleral lenses have been developed to fill this gap. With a diameter ranging from 14 mm to 15 mm, these lenses incorporate the principles of minimal movement and reduced lid interaction seen in soft contact lenses. The larger overall diameter provides comfort benefits, as the lens edge is tucked under both upper and lower lids, preventing direct contact with the sensitive lid margins. This design eliminates a common cause of foreign body sensation associated with Rigid Gas Permeable (RGP) lenses. The product’s advantages, including improved comfort and reduced irritation, contribute to its growing popularity in the market.
Based on the Application, the Scleral Lenses Market has been segmented into Irregular Cornea, Ocular Surface Disease, Refractive Error, and Other Applications. The Irregular Cornea segment was expected to hold the largest market share in 2022. Irregular corneas often result in distorted vision, and traditional glasses or contact lenses may not sufficiently correct these issues. Scleral lenses, which conform to the shape of the sclera rather than directly interacting with the sensitive corneal surface, effectively address irregularities in the cornea. This tailored approach provides enhanced vision correction and visual acuity, particularly beneficial for conditions like keratoconus.
Competitive Landscape
ABB Optical Group, Bausch Health Companies Inc., Visionary Optics, Essilor, Art Optical Contact Lens, Inc., CooperVision, BostonSight, AccuLens, Inc., Tru-Form Optics, SynergEyes, Valley Contax, Capricornia and Menicon Co., Ltd
Regional Analysis
The global Scleral Lenses Market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of the US and Canada. The Europe Scleral Lenses Market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Scleral Lenses Market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World’s Scleral Lenses Market comprises of Middle East, Africa, and Latin America.
Browse In-depth Market Research Report (128 Pages) on Scleral Lenses:
https://www.marketresearchfuture.com/reports/scleral-lenses-market-19204
The largest market share for the Scleral Lenses Market was maintained by the North American regional sector. The United States plays a pivotal role in the scleral lenses market, driven by a higher prevalence of eye diseases and injuries. The growth is exemplified by statistics from the National Eye Institute, which reported approximately 12 million residents in the United States diagnosed with low vision in 2022. This figure is expected to rise significantly, reaching around 50 million by 2030. Furthermore, a Center for Disease Control and Prevention report highlighted that in 2019, approximately 54 million individuals aged 18 or older in the United States, constituting about 22.1% of the adult population, were users of scleral lenses. This upward trend is poised to contribute to the expansion of the scleral lenses market in the country throughout the forecast period.
Discover More Research Reports on Healthcare Industry by Market Research Future:
Moreover, the Europe market has been persistently growing over the forecast period. Various eye conditions, such as irregular corneas, keratoconus, and other corneal irregularities, impact a significant portion of the European population. Geographically, Europe is home to an estimated over 30 million individuals who are blind or partially sighted. On average, approximately 1 in 30 Europeans undergo some degree of sight loss. The European Blind Union (EBU) leans toward an estimated 30 million visually impaired individuals. In addressing these conditions, scleral lenses emerge as an effective solution for vision correction, thus fueling the increasing demand for such lenses.
Chronic Lymphocytic Leukemia Treatment Market Research Report Information By Type (Indolent, Aggressive, and Others), By Treatment (Chemotherapy, Targeted Drug Therapy, and Immunotherapy & Bone Marrow Transplant), By End User (Hospitals and Specialty Clinics), And By Region (North America, Europe, Asia-Pacific, And the Rest Of The World) – Market Forecast Till 2032.
Viral Vectors and Plasmid DNA Manufacturing Market Research Report Information By Vector Type (Plasmid DNA, Viral Vector, Non-viral Vector), By Disease Type (Cancer, Genetic Disorder, and Infectious Disease), By Applications (Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, and Research), By Workflow (Upstream Processing and Downstream Processing), By End User (Pharmaceutical and Biopharmaceutical Companies, and Research Institutes), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast
Global Nasal Drug Delivery Market Research Report Information by Drug Type (Anesthetics, Antibiotics), Dosage Form (Drops, Sprays), Basis of System (Unit Dose, Multi-Dose), Delivery Technologies (Spray, Nebulizers), Therapeutic Applications (Rhinitis, Asthma) End User (Home Care Settings) and Region (the Americas, Europe, Asia-Pacific, and the Middle East & Africa)—Forecast till 2032.
Porcine Vaccines Market Research Report Information by Type (Inactivated Vaccines, DNA Vaccines), Disease Indication (Diarrhea, Swine Influenza), End User – Forecast Till 2030
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
